Anselmo Pharma SRL
Anselmo Pharma reported total assets of 960,281 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Aug 2026).
The score of Anselmo Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +198 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Anselmo Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Aug 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
Anselmo Pharma's financial analysis
- Solvency19.1%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Anselmo Pharma
Anselmo Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0798.184.888
- VAT number
- BE0798184888
- Peppol
- Registered · 0208:0798184888 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Feb 2023
- Registered office
- 2018 Antwerp
- Latest accounts
- 2025 · filed on 10 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Anselmo Pharma (SRL) has been based in Antwerp since 2023, active in: activities of holding companies. For 2025, it reports a net profit of 62,258 € and equity of 183,073 €; its revenue is not published. Its solvency stands at 19.1%, below the median of its sector (55.6%).
Companies similar to Anselmo Pharma
Companies in the same business, of comparable size and area, outside its group.
- Griet Invest Activities of holding companies Ghent · balance sheet 960,619 €
- AGOC Activities of holding companies Bilzen-Hoeselt · balance sheet 961,384 €
- Parc Panorama Activities of holding companies Liège · balance sheet 961,397 €
- Heran Partners II Activities of holding companies Antwerp · balance sheet 963,208 €
- Group GLJ Invest Activities of holding companies As · balance sheet 956,243 €
- Tibint Activities of holding companies Roosdaal · balance sheet 956,125 €
- R & S Management Consultancy Activities of holding companies Aalst · balance sheet 955,446 €
- GMT+ Activities of holding companies Hoogstraten · balance sheet 965,514 €
Frequently asked questions about Anselmo Pharma
What is the revenue of Anselmo Pharma?
Anselmo Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Anselmo Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0798184888 for Anselmo Pharma, if the company is VAT-registered. Its company number (CBE) is 0798.184.888.
Where is the registered office of Anselmo Pharma?
According to the CBE register, the registered office of Anselmo Pharma is in 2018 Antwerp.
What is the equity of Anselmo Pharma?
At the close of the 2025 financial year, the equity of Anselmo Pharma amounts to 183,073 €, a solvency of 19.1% of total assets.
Who manages Anselmo Pharma?
The register lists 1 active mandates at Anselmo Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Anselmo Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →